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Objective

To identify characteristics that contribute to and promote a pharmacy services center of
excellence model in a large health system.

Methods

In 2019, a survey was conducted of 161 acute care pharmacy departments of health system-affiliated hospitals. Information captured included pharmacy practice models, pharmacist resource allocation, training of pharmacy residents, postgraduate training and pharmacist certifications. Results were combined with clinical pharmacy metric performance and
centralized electronic data to identify features of top performing pharmacy departments.
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Results

Survey results were received from 141 of 161 affiliated hospitals (88%). Hospitals with 100 to
299 beds comprised 54% (n = 16 of 30) of the hospitals “at goal” and 66% (n = 26 of 40) of
hospitals with “opportunity”. Hospitals with top performing pharmacy services had greater
participation in interdisciplinary rounds, reporting “always” participating in Adult Critical Care
(67% versus 43%) and Medical/Surgical (30% vs. 8%) rounds. Hospitals that trained pharmacy residents had a greater number of clinical pharmacy metrics at goal (5.89 ± 1.59 versus
4.16 ± 1.86, p < 0.001), employed more board-certified pharmacists (2.32 ± 1.49 versus 1.57 ±
1.62, p = 0.019), more postgraduate year 1 (PGY1) trained pharmacists (2.06 ± 1.33 versus 1.19 ±
1.19, p < 0.001) and more PGY2 trained pharmacists (0.58 ± 0.64 versus 0.19 ± 0.44, p = 0.002).
When including several key hospital characteristics into a single model, hospitals that trained
pharmacy residents were significantly associated with achieving “at goal” status (p = 0.011).

Conclusion

Defining characteristics of a pharmacy services center of excellence model included “at goal”
clinical pharmacy metrics performance, clinical pharmacist time dedicated to patient care
activities, accredited pharmacy residency training programs, presence of pharmacists with
advanced training or board certification and optimal operations and scheduling.
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Introduction

Benefits of pharmacist-delivered patient care
include reduction in medication errors, adverse
events, mortality and costs resulting in improved patient outcomes and financial performance.1-5 While literature describes hospital and

health system pharmacy models that expand
pharmacist roles to include greater clinical
patient care activities, the extent of clinical
pharmacist services allocation varies based
on operational workflow and resources.6-9 In
2020, the ASHP Pharmacy Forecast provid-
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ed strategic recommendations for leaders to
advance pharmacy practice through center of
excellence recognition.5 It is anticipated that
designation as a pharmacy services center of
excellence may improve organizational branding and recruitment of the best talent. However, measures resulting in outstanding patient
and organizational outcomes have not been
defined.1,10,11
Our health system sought to identify successful pharmacy services with the goal of advocating for the implementation of best practices to
other pharmacy departments. Our organization
used internal survey results, clinical pharmacy
metrics performance and health system electronic data to identify high-performing pharmacy departments. After collating the results,
an assessment tool was developed based on
ASHP Practice Advancement Initiative 2030
recommendations.12 This initiative explored
themes to support continued advancement
of the pharmacy profession in areas such as
patient-centered care, use of data and technology, roles of pharmacists/pharmacy technicians
and medication use safety.12 This paper aims
to describe optimization opportunities and
supporting evidence for pharmacy leaders to
strategically pursue characteristics of a pharmacy services excellence model.

Methods

An internally conducted survey was distributed
in February 2019 to 161 acute care pharmacy
departments, each representing individual
affiliated hospitals in our health system. Exclusion criteria were acute care hospitals that did
not have Clinical Pharmacist Workflow (CPW)
real time surveillance technology implemented,
results for fewer than 9 of 10 clinical pharmacy
metrics (minimum denominators were required
for each metric), incomplete survey responses and single service line hospitals. The survey
included a glossary of terms and definitions
along with explicit instructions in an effort to
limit interpretation bias and was piloted by two
hospitals prior to distribution. Hospital pharmacy departments were instructed to provide
information based on calendar year 2018 and
report their bed size, presence of satellite pharmacies and hours of operation (i.e., non-24 hour
pharmacy services, 24-hour pharmacy services).
They were also asked to use standard shift

368

times in their survey responses, defined as first
shift (0700 – 1500), second shift (1500 – 2300)
and third shift (2300 – 0700).
Clinical pharmacist was defined as a pharmacist who performed clinical activities other than
order entry, order verification and dispensing
functions (e.g., checking automated dispensing
cabinet lock-lidded pockets, checking intravenous admixtures) and did not include pharmacy residents or students. Clinical pharmacist
allocation was defined as dedicating time and
resources to clinical activities other than order
entry, verification and dispensing functions.
Clinical pharmacy specialist was defined as a
pharmacist that spent greater than or equal to
70% of their time performing clinical activities
in a specialized area of practice (e.g., internal
medicine, oncology, cardiology and antimicrobial stewardship). The overall level of training
involved board certifications, residency completion and other programs that required additional expertise. Patient care activities were
defined as clinical pharmacists available and
located physically outside of the main pharmacy department (decentralized) dedicated
to performing activities, not including order
entry/verification. Clinical pharmacist time
spent performing patient care activities was
further defined as one of the following: 1) They
spent less than 25% of their time performing
patient care activities, with interaction occurring only during order verification/performing
operational functions or when pharmacy presence on each of the floors was inconsistent; 2)
They spent 25–50% of their time performing
patient care activities, but their interactions to
influence patient therapy were limited due to
operations responsibilities, other factors or the
pharmacist presence on each of the floors was
often inconsistent; 3) Greater than 51% to 75%
of their time was spent on patient care activities and interacting with the health care team
to influence patient therapy with the service
provided on each of the floors consistently;
4) Greater than 75% of their time was spent
interacting with the health care team to influence patient therapy and manage medication
therapy for health care providers, with the service provided on each of the floors consistently;
or 5) there was a variation not described in 1
through 4. Interdisciplinary rounds, rounds and
rounding were defined as in-person interdisciplinary meetings in any setting where a physi-
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cian or other type of provider was available to
discuss patient care with the health care team
where the pharmacist was able to make recommendations and perform interventions. Study
approval was received by the University of
Tennessee Health Science Center Institutional
Review Board.
Survey question responses captured pharmacy
services practice models, pharmacist resource
allocation, training of pharmacist residents,
pharmacist postgraduate training and pharmacist certifications. In combination with centralized staffing data, survey responses were used
to evaluate clinical pharmacist to inpatient
ratios, clinical pharmacists’ specialties, allocation of clinical pharmacist time and pharmacist
time spent in interdisciplinary rounds. Clinical
pharmacy metrics were used as a proxy to
indicate the strength of the pharmacy’s clinical
services. Our health system reported metric
performance monthly by hospital. Performance
to goal was not adjusted for pharmacist coverage by shift or day of the week. A composite
of 10 individual clinical pharmacy metrics for
performance to goal were used to benchmark
pharmacist impact on medication therapy outcomes:
• Response time to potential high priority
clinical interventions (Goal ≤ 4 hours)
• Completed interventions (Goal ≥ 40%)
• Oral to intravenous (IV) dose ratios (Goal ≥
70%)
• IV to oral conversion (Goal ≥ 50%)
• Warfarin administration and subsequent
international normalized ratio (INR) > 5
(Goal ≤ 3%)
• Oral to IV opioid dose ratio (Goal ≥ 70%)
• Proton-pump inhibitor (PPI) and histamine
2 (H2) receptor blocker days of therapy per
1,000 patient days present (Goal rate decreased by at least 10% or rate is less than
200)
• Antimicrobial de-escalation (Goal ≥ 30%)
• Vancomycin troughs within range (Goal ≥
80%)
• Fluoroquinolone use in urinary tract infection (UTI) (Goal ≤ 20%).
Pharmacy departments with the most clinical
pharmacy metrics at goal identified top performing hospitals, and, conversely, hospitals
with the least number of metrics at goal identified hospitals with the greatest opportunity
for improvement. Breakpoints were established

based on 2018 metric performance goals, which
were in place for the time period informing the
survey responses. Within each bed size category, hospitals with greater than or equal to 7
metrics at goal were defined as at goal. Those
with 4 to 6 metrics at goal were defined as
close to goal. Hospitals with less than or equal
to 3 metrics at goal were defined as hospitals
with opportunity. A comparison of hospitals
at goal and with opportunity was completed
to determine the optimal pharmacy services
model to support the best medication therapy
outcomes.
Results were examined by hospital demographics, including pharmacy hours of operation,
number of beds, service lines, average daily
census, adjusted patient days (APD), average length of stay (LOS), percent-completed
interventions and cost savings per intervention.
To assess pharmacist to inpatient ratios in the
adult critical care and medical/surgical units, a
subgroup of respondents, representing the majority high-performing pharmacy departments
by geographic area, was evaluated for further
analysis.

Statistical Analysis

Descriptive statistics were used to detail the
characteristics of the hospitals and their pharmacy models. To test for associations between
categorical variables, chi-squared tests or Fisher’s exact tests were used. Two-sample t-tests
were used to assess the relationship between
level of training, presence of residency programs and clinical pharmacy metrics. Logistic
regression was used to assess the relationship
between achieving status of an at-goal hospital and key hospital characteristics. Statistical
analyses were done in Microsoft Excel (Microsoft Corporation; Redmond, Washington) and
R (R Foundation for Statistical Computing;
Vienna, Austria).

Results

In our health system, 161 acute care hospital
pharmacy departments had CPW implemented. Responses were received from 141 (87.6%)
surveyed hospital pharmacy departments.
A total of 8 hospitals were excluded from
the results. Four hospitals submitted incomplete surveys. Two hospitals did not meet the
threshold for 9 of 10 metrics. Two hospitals
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Figure 1. Number of hospitals listed by bed size category.
were single service line hospitals. A total of 133
hospital pharmacy departments were included
in the analysis. Thirty hospitals were identified as “at goal”, 63 were identified as “close to
goal” and 40 hospitals were identified as with
“opportunity”. Survey respondent pharmacy
departments were first considered by bed
size category groupings and number of clinical pharmacy metrics at goal. Hospitals were
stratified in the following bed size categories:
less than 50 beds, 50 to 99 beds, 100 to 199
beds, 200 to 299 beds, 300 to 399 beds, 400
to 599 beds, and greater than or equal to 600
beds. The majority of hospitals, 56% (n = 74),
reported between 100 and 299 beds. (Figure 1)
Distribution of at-goal hospitals, close-to-goal
hospitals and hospitals with opportunity by bed
size categories were assessed. (Table 1)
A logistic regression model was used to assess
the relationship between at-goal hospitals

and key hospital characteristics. When including several key hospital characteristics into a
single model, hospitals that trained pharmacy
residents were significantly associated with
achieving at-goal status (p = 0.011). (Table 2)
Among survey respondents (n = 133), 35 (26%)
hospitals reported training pharmacy residents.
Of the 35 hospitals that trained pharmacy residents, 50% (n = 15 of 30) of at-goal hospitals
and 5% (n = 2 of 40) of hospitals with opportunity were included.
A statistically significant difference was found
between hospitals that trained pharmacy
residents and those that did not in several
key areas. (Table 3) On average, hospitals that
trained pharmacy residents were found to have
a greater number of clinical pharmacy metrics
at goal (5.89 ± 1.59 versus 4.16 ± 1.86, p < 0.001).
Hospitals that trained residents also employed
more board-certified pharmacists (2.32 ± 1.49

Table 1. Hospitals with Clinical Pharmacy Metrics at Goal
“At Goal” Hospitals
“Close to Goal” Hospitals
Bed Size
n = 30 (%)
n = 63 (%)
Category
7 to 10 Metrics at Goal
4 to 6 Metrics at Goal

0 to 3 Metrics at Goal

< 50

0 (0%)

3 (5%)

3 (8%)

50–99

2 (7%)

8 (13%)

2 (5%)

100–199

11 (37%)

16 (25%)

7 (18%)

200–299

5 (17%)

16 (25%)

19 (48%)

300–399

4 (13%)

10 (16%)

5 (13%)

400–599

6 (20%)

6 (10%)

4 (10%)

2 (7%)

4 (6%)

0 (0%)

≥ 600
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“Opportunity” Hospitals
n = 40 (%)
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Table 2. Contributing Factors of Hospitals with ≥ 7 Clinical Pharmacy Metrics “At Goal”*
Factor
Odds Ratio
95% Odds Ratio CI
p value
Number of Board-Certified Pharmacists
(Per 100 Beds)

1.32

(0.92, 1.90)

0.133

Residency Training Program (Yes vs. No)

3.66

(1.35, 9.94)

0.011

Number of PGY1 and PGY2 Trained
Pharmacists (Per 100 Beds)

0.87

(0.58, 1.30)

0.503

≥ 51% of Clinical Pharmacist Time Dedicated
to Patient Care Activities (First Shift)

2.27

(0.73, 7.00)

0.154

*Hospitals (n = 124) responding to all factors above are included

versus 1.57 ± 1.62, p = 0.019), more postgraduate year 1 (PGY1) trained pharmacists (2.06 ±
1.33 versus 1.19 ± 1.19, p < 0.001) and more PGY2
trained pharmacists (0.58 ± 0.64 versus 0.19 ±
0.44, p = 0.002) than hospitals without residency training programs. (Table 3)
Overall, pharmacy departments achieved
greater than or equal to 7 metrics at goal when
a greater percentage of pharmacists’ time was
dedicated to patient care activities (less than
or equal to 50% dedicated time: n = 3 at goal
hospitals versus n = 12 hospitals with opportunity). (Figure 2) Weekday, unit-based clinical
pharmacist coverage was also evaluated; 73%
(n = 22) of at-goal hospitals had first shift pharmacists providing clinical services compared to
48% (n = 19) of opportunity hospitals. Limited
unit-based pharmacist coverage was noted for
all shifts on weekends with 20% of both atgoal (n = 6) and opportunity (n = 8) hospitals
reporting first shift unit-based clinical pharmacy services. Only 14 hospitals (47%) meet-

ing at-goal criteria (n = 30) reported rotating
clinical pharmacists through different areas on
a weekly basis compared to 27 hospitals (68%)
with opportunity (n = 40). The average number
of different pharmacists covering clinical areas
on weekdays during first shift was also less for
at-goal hospitals compared to hospitals with
opportunity for 5 of 8 service lines (i.e., lower
average number of different pharmacists indicated consistency in pharmacist scheduling).
(Table 4)
More at-goal hospitals reported dedicated
clinical pharmacist coverage than hospitals
with opportunity for adult critical care (70%
versus 63%), behavioral health (23% versus
10%), emergency department (30% vs. 20%),
hematology/oncology (27% versus 23%) and
medical/surgical (57% versus 45%) service
lines. Hospitals reporting always participating
in rounds were greatest for adult critical care
(n = 64, 48%), medical/surgical (n = 18, 14%)
and neonatal intensive care units (n = 64, 48%).

Table 3. Comparison of Hospitals with and without Pharmacy Residency Training Programs
Hospitals with Pharmacy
Hospitals without PharResidency Training
macy Residency Training
Programs
Programs
(n = 35 hospitals)
(n = 89 hospitals)
Hospital Characteristics
p value
Mean ± SD
Mean ± SD
Clinical Pharmacy Metrics At
Goal

5.89 ± 1.59

4.16 ± 1.86

<0.001

Board-Certified Pharmacists
(Per 100 Beds)

2.32 ± 1.49

1.57 ± 1.62

0.019

PGY1 Trained Pharmacists
(Per 100 Beds)

2.06 ± 1.33

1.19 ± 1.19

<0.001

PGY2 Trained Pharmacists
(Per 100 Beds)

0.58 ± 0.64

0.19 ± 0.44

0.002

PGY1 or 2 Trained Pharmacists (Per 100 Beds)

2.63 ± 1.72

1.39 ± 1.33

<0.001
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For at-goal hospitals, the distribution of participation in interdisciplinary rounds was more
heavily weighted towards greater than 50%
of the time responses, with distribution more
heavily weighted at less than 50% of the time
responses for opportunity hospitals. At-goal
hospitals reported always participating in adult
critical care (67% versus 43%) and medical/surgical (30% versus 8%) rounds more than hospitals with opportunity. Clinical pharmacists in
at-goal hospitals dedicated twice as much time
per month on average to hospital committees
compared to hospitals with opportunity (12 ± 21
versus 6 ± 10).
A subgroup analysis was completed by geographic area to encompass the majority
high-performing pharmacy departments to

further discern pharmacist-to-patient ratios
of at-goal hospitals. This subset included 49
hospitals from 4 United States geographic
areas: the Northeast, Midwest, South Central
and South. Within the subset were 22 hospitals
at goal and 4 hospitals with opportunity. The
at-goal hospitals within the subset represented
73% (22 of 30) of the full data set of hospitals
at goal with 100 to greater than or equal to
600 beds. The average pharmacist-to-inpatient
ratios were evaluated for an average weekday
on first shift for the at-goal subgroup. For atgoal respondents, medical/surgical units were
found to have an average pharmacist-to-patient ratio of 1 pharmacist to 48 patients on
weekdays, first shift. In the adult critical care
unit, this ratio was 1 pharmacist to 23 patients
on weekdays during the first shift. The at-goal

Table 4. Consistency in Pharmacist Coverage on Weekdays, First Shift
Number of Different Pharmacists Rotated Through a Patient
Care Area on Weekdays, Avg ± SD*
Patient Care Area

At-Goal Hospitals

Opportunity Hospitals

Neonatal Intensive Care Unit

1±0

5±9

Pediatric Unit

1±0

3±3

Pediatric Intensive Care Unit

1±1

4±3

Behavioral Health

1±1

4±3

Medical / Surgical

3±3

4±7

Adult Critical Care

2±1

2±1

Emergency Department

2±1

2±1

Hematology / Oncology

2±1

2±1

*Bold font indicates greater consistency in pharmacist coverage of “At Goal” Hospitals compared to “Opportunity” Hospitals
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Table 5. At-Goal Subgroup Pharmacist-to-Patient Ratios (First Shift, Weekdays)
Patients Per Pharmacist, n
Patient Care Unit, h*

Average

Range

Adult Critical Care, h = 22

23

4–98

Behavioral Health, h = 22

47

13–70

Emergency Department, h = 22

40

0–125

Hematology/Oncology (inpatients), h = 18

39

10–72

Medical/Surgical, h = 22

48

5–92

Neonatal ICU, h = 14

28

3–68

Pediatric ICU, h = 10

10

4–16

Pediatrics, h = 10

16

3–36

*h = Number of hospitals contributing to the pharmacist to patient ratios for each Patient Care Unit type;
subgroup hospitals provided number of pharmacist productivity hours per area (some pharmacists covered multiple areas) and average number of patients by Patient Care Unit

subgroup ratios for all service lines were also
evaluated. (Table 5)

Discussion

Our health system includes over 180 acute
care hospitals in 21 states and employs approximately 5,500 pharmacists. Approximately
1.9 million hospital admissions and 9.2 million
emergency room visits occur each year across
this health system. According to IBM Watson Health's 2020 "100 Top Hospitals" annual
study, 17 hospitals in our health system were
recognized as best performers in the nation.13
Pharmacy services in our health system vary
based on hospital size, staffing matrix, resource allocation and services provided. Clinical
activities are completed 24 hours per day, 7
days per week regardless of whether hospitals have non-24 hour or 24-hour pharmacy
services. Clinical pharmacy services include
safe and effective medication use through
drug selection, timing of therapy, monitoring
for therapeutic outcomes and adverse events,
drug therapy optimization, interdisciplinary
rounding, daily electronic health record review,
pharmacy directed consults and collaboration
with the care team.
In 2005, our health system began initiatives
to provide the framework to support the goal
of 24/7 clinical pharmacy services. Pharmacist-delivered patient care improves patient
outcomes, increases cost efficiency and alleviates pressures on the healthcare system.8,9
However, competing priorities and responsi-

bilities coupled with inefficient processes and
workflow can dramatically reduce the amount
of time pharmacists are able to dedicate to
comprehensive patient-centered care. Traditional pharmacist-to-patient ratios have been
reported as ranging from 1:50 to 1:100, with
suggested ratios of 1:20 (ICU specific) to 1:30
for optimal care.14 Survey results revealed most
unit-based pharmacist resources are located
in the adult critical care and medical/surgical
units, and adult critical care pharmacist-to-patient ratios were lower in comparison to the
ratio in medical/surgical units. The subgroup
hospitals which informed the ratios were
selected to include a geographically diverse
sample of high performing pharmacy departments. The ratio ranges from this subgroup
highlighted the variability in clinical pharmacist allocation by area. The range of ratios was
comparable in both the adult critical care and
medical/surgical units and the largest range
was reported in the emergency department.
Adult critical care units have higher patient
acuity and require more resources including
lower patient to pharmacist ratios. From
this data, we were able to optimize pharmacist-to-patient ratios in the medical/surgical
units, thereby allowing clinical pharmacists to
deliver more comprehensive services. Pharmacists use CPW, a real time surveillance
technology that captures patient-specific data
from the electronic health record, to improve
patient safety and streamline the daily workflow. CPW empowers pharmacists to anticipate, identify and prevent adverse drug events.
CPW also optimizes drug therapy by creating
373
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more timely responses to IV to oral medication
conversions, renal dosing adjustments, antimicrobial management program interventions
and drug-laboratory triggers. For the past 3
years, clinical pharmacy metrics have measured
medication therapy outcomes tied directly
to clinical pharmacist services by using parameters from CPW such as laboratory data,
medication administration data and ICD-10
diagnosis codes. The metrics are measured on
actual results or outcomes and are not reliant
on documentation.
Hospitals must have achieved greater than
or equal to 7 clinical pharmacy metrics to be
considered at goal. These hospitals demonstrated optimization of the workflow and
continuously performed clinical pharmacy
services around the clock. Of hospitals in our
health system that were at goal, unit-based
pharmacists spent greater than 75% of their
time performing direct patient care activities
compared to hospitals with opportunity. It is
not surprising that results comparing at-goal
and opportunity hospitals revealed that atgoal hospitals dedicated more pharmacist time
to patient care activities, consistently scheduled the same clinical pharmacists to cover
designated clinical areas weekly and provided
greater dedicated clinical pharmacist service line coverage. Consistent operations and
scheduling to provide optimal patient care was
demonstrated to be an important differentiator between at-goal hospitals and hospitals
with opportunity. These results indicated that
ensuring pharmacist time dedicated to patient
care activities benefited patients as reflected
by clinical pharmacy metric performance.
Furthermore, 50% of at goal hospitals trained
pharmacy residents compared to 5% of opportunity hospitals. The year 2018 encompassed
portions of 2 residency years, and growth was
seen in the number of residents trained from
residency year 2017–2018 to 2018–2019. Over
this period there was an 18% growth in PGY1
residents trained (67 to 79), and the number
of PGY2 residents trained more than doubled
(14 to 29). Hospitals that trained pharmacy
residents were significantly associated with
achieving at goal status, connecting residency programs to improved clinical pharmacy
metric performance. Survey results reported
nearly 600 residency-trained pharmacists
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and 444 Board of Pharmacy Specialties (BPS)
certified pharmacists working in our health
system’s pharmacies. Hospitals with residency
programs employed significantly more pharmacists statistically with advanced training or
board-certification, which supports continued development of innovative models that
promote the pharmacist’s role in an advanced
level of practice.6,9,15-19 Pharmacy practice models vary by organization, hospital and services
offered, and direct clinical patient care continues to expand to pharmacist credentialing and
privileging.6,7,20-25 In 2018, 32.3% of 811 surveyed
hospitals reported pharmacist privileged activities that included prescribing medications
pursuant to diagnosis of a medical disease or
condition.25 While center of excellence specific
qualities and metrics have not been formally
established, survey results and internal data
were used to identify programs that fit this
model and support the future growth of our
health system’s pharmacy services. The defining characteristics of our center of excellence
model represented in Figure 3 included: 1) Atgoal clinical pharmacy metrics performance,
2) Clinical pharmacist time dedicated to
patient care activities, 3) Accredited pharmacy
residency training programs, 4) Presence of
pharmacists with advanced training or board
certification, and 5) Optimal operations and
scheduling.
At goal hospitals spent twice as much time
serving on committees compared to hospitals
with opportunity. Clinical pharmacist representation on committees promotes visibility and
the ability to advocate for evidence-based best
practices, which enhances medication therapy
outcomes. With insight that clinical pharmacist scheduling consistency provides greater
continuity of care, ownership of the patient
care unit and improved healthcare professional
rapport, a pharmacy services model assessment tool was developed for pharmacy leaders
to evaluate services provided daily by shift by
employee. This tool is completed and reviewed
semi-annually to ensure clinical pharmacist
time is optimized. (Appendix 1) Recognizing
pharmacy programs that embody this center
of excellence model will support the growth of
pharmacy services across our health system.
Our survey had several limitations, including reliance on respondent survey responses,
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Figure 3. A diagram showing the characteristics of the Health System Pharmacy Services Center
of Excellence Model.
descriptive nature of responses and interpretation bias. While the survey was constructed
to limit the variability of responses, there were
survey questions that respondents did not
answer or selected as "other" and provided
free text explanation. This hospital-specific
detail was challenging to incorporate into the
analysis. According to the Centers for Disease
Control and Prevention (CDC) health trends,
47% (n = 2,301) of reporting hospitals indicated
greater than or equal to 100 beds in 2015.26 Our
results revealed that the majority of at-goal
hospitals were greater than or equal to 100
beds and only included 2 hospitals with less
than or equal to 99 beds. Nearly 50% of United
States hospitals are similar in size to defining
characteristics of at-goal hospitals studied and
are relevant considerations when implementing a pharmacy services center of excellence
model. An area of future study will include
smaller sized hospitals that have hybrid clinical/operational pharmacy services models, as
there may be limited applicability of results for
smaller sized hospitals.
While the subgroup analysis of manageable
pharmacist-to-patient ratios appeared to be
associated with optimized clinical pharmacy
services, future research is needed to further
understand the ideal pharmacist ratios required to improve patient outcomes. Areas
of future study include validation of optimal
best practice models, specifically the impact
of advanced pharmacist training, board cer-

tification and accredited residency programs
on achieving clinical pharmacy metric goals
and improved patient outcomes. As at-goal
hospitals were larger in size, additional study
is needed to identify excellence models for
pharmacy services with hospitals less than or
equal to 99 beds.

Conclusion

Survey results and internal data were used
to identify excellence qualities for our health
system’s pharmacy services. Defining characteristics of our pharmacy services center of
excellence model included at-goal clinical pharmacy metrics performance, pharmacist time
dedicated to patient care activities, accredited
pharmacy residency training programs, presence of pharmacists with advanced training
or board certification and optimal operations
and scheduling. Pharmacy services assessment
results have encouraged health system leaders
to implement actions to achieve and advance
pharmacy services best practice models to
improve patient care.
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